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Abstract
Background: More than 80% of mammalian protein-coding genes are driven by TATA-less promoters which often show
multiple transcriptional start sites (TSSs). However, little is known about the core promoter DNA sequences or mechanisms
of transcriptional initiation for this class of promoters.
Methodology/Principal Findings: Here we identify a new core promoter element XCPE2 (X core promoter element 2)
(consensus sequence: A/C/G-C-C/T-C-G/A-T-T-G/A-C-C/A+1-C/T) that can direct specific transcription from the second TSS of
hepatitis B virus X gene mRNA. XCPE2 sequences can also be found in human promoter regions and typically appear to
drive one of the start sites within multiple TSS-containing TATA-less promoters. To gain insight into mechanisms of
transcriptional initiation from this class of promoters, we examined requirements of several general transcription factors by
in vitro transcription experiments using immunodepleted nuclear extracts and purified factors. Our results show that XCPE2-
driven transcription uses at least TFIIB, either TFIID or free TBP, RNA polymerase II (RNA pol II) and the MED26-containing
mediator complex but not Gcn5. Therefore, XCPE2-driven transcription can be carried out by a mechanism which differs
from previously described TAF-dependent mechanisms for initiator (Inr)- or downstream promoter element (DPE)-
containing promoters, the TBP- and SAGA (Spt-Ada-Gcn5-acetyltransferase)-dependent mechanism for yeast TATA-
containing promoters, or the TFTC (TBP-free-TAF-containing complex)-dependent mechanism for certain Inr-containing
TATA-less promoters. EMSA assays using XCPE2 promoter and purified factors further suggest that XCPE2 promoter
recognition requires a set of factors different from those for TATA box, Inr, or DPE promoter recognition.
Conclusions/Significance: We identified a new core promoter element XCPE2 that are found in multiple TSS-containing
TATA-less promoters. Mechanisms of promoter recognition and transcriptional initiation for XCPE2-driven promoters appear
different from previously shown mechanisms for classical promoters that show single ‘‘focused’’ TSSs. Our studies provide
insight into novel mechanisms of RNA Pol II transcription from multiple TSS-containing TATA-less promoters.
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Introduction
Recent bioinformatics studies have revealed that most mam-
malian genes do not conform to the simple model in which a
TATA box directs transcription from a single defined nucleotide
position –most genes have multiple promoters, within which there
are multiple start sites, and that 72% of human promoters are
associated with CpG islands [1–3]. It has been also reported that
the majority of strong human RNA polymerase II (RNA pol II)
core promoters have an array of closely located transcriptional
start sites (TSSs) that are spread over 50–100 bp [4], which is
different from the traditional view that ‘‘true’’ or ’’truly specific’’
transcriptional initiations show single (or ‘‘focused’’) TSS. Broad
TSS distributions (‘‘dispersed’’ TSSs) are correlated with CpG
islands and ubiquitously expressed genes, whereas promoters with
a narrow TSS distribution frequently direct tissue-specific genes
and often have a TATA box. [5]. The frequency of TATA box
containing promoters among human protein-coding genes is now
estimated to be 10–20% [2,3,6].
Ironically, most of the studies examining fundamental mecha-
nisms of transcriptional regulation have been carried out using
promoters that have ‘‘focused’’ start sites, particularly, TATA-
containing promoters. Thus, how the transcriptional machinery
recognizes ‘‘dispersed’’ promoters and initiates transcription from
multiple, individual TSSs (or ‘‘TS regions’’) is still poorly
characterized. A number of questions remain regarding the
mechanisms at play for promoters utilizing multiple start sites;
(1) whether individual start sites are specifically driven by definitive
core promoter elements or whether a single ‘‘loose’’ element can
drive transcription from multiple locations, (2) how transcription
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regulated, (3) which general transcription factors (GTFs) are used
for transcription from different start sites at these types of
promoters, and (4) whether a stable preinitiation complex is
formed for transcriptional initiation from each start site. (5)
Previously identified core promoter elements including the TATA
box, the initiator (Inr), the downstream promoter element (DPE),
the TFIIB recognition element (BRE), the motif ten element
(MTE), downstream core element (DCE), and XCPE1 [6–11] are
not present in a large number of genes in the mammalian genome
[6,7,12,13]. Are there other as yet unidentified sequences
responsible for transcriptional activity? To address these questions,
we must identify which DNA sequences (i.e., core promoter
elements) are essential to drive transcription from each TSS,
examine the properties of these newly identified core promoters,
and subsequently determine GTF and cofactor requirements for
these newly identified promoters.
In this report, using extensive mutagenesis we identify a novel
DNA sequence that functions as a core promoter element at the
second start site of the hepatitis B virus (HBV) X mRNA which we
have named XCPE2 (X core promoter element 2). The core
promoter containing XCPE2 is located in one of the CpG islands
of the HBV genome in a similar way to observed TSSs in the
human genome. Our search of promoter database shows that
XCPE2 like sequences also appear to be present in human TATA-
less promoters and typically drive one of the start sites present
within multiple TSS-containing promoters. Our in vitro transcrip-
tion analyses using immunodepleted nuclear extracts with purified
GTFs show that XCPE2-driven basal transcription requires at
least RNA pol II, TFIIB, MED26-containing mediator, and either
a free form of TBP or TFIID. We further show in this report that
XCPE2-driven transcription is Gcn5-independent and therefore is
independent of TFTC [14] or STAGA [Spt3-TAFII31-Gcn5-L-
acetyltransferase] [15] (human homologue of yeast SAGA)
complex. We also observed in our in vitro transcription analyses
with cellular XCPE2-containing promoters that transcription from
not only the XCPE2-driven TSSs but also other TSSs in the
XCPE2-containing promoter regions show similar GTF require-
ments to those of the X gene promoter. Our study on XCPE2-
driven transcription also provides, in our knowledge, the first
example that clearly demonstrates mediator-dependent basal (but
not activated) transcription from TATA-less promoters. This
property may potentially be applied to many other promoters
localized in CpG islands. Our studies provide essential information
to help understand mechanisms of RNA Pol II transcription from
dispersed promoters.
Results
Determination of the core promoter element for
transcription from Start site 2 of the HBV X mRNA
We previously localized the core promoter activity for
transcription from Start site 2 of the HBV X mRNA to a 13-bp
DNA region between nt1020 and 1032 (CCCCGTTGCC+1CGG)
that was located between 29t o+4 relative to Start site 2 (Fig. 1A,
pX1020/1032CAT and [6]). This 13-bp DNA fragment could
drive unidirectional transcription from the specific start site either
in the context of HBV DNA or by itself when cloned into a
reporter plasmid. Transcription activity of this 13-bp minimal
promoter is about the same as Start site 2 transcription activity of
the enhancer-containing constructs when measured by the in vitro
transcription assays using naked DNA templates. However, it is
lower than the Start site 2 transcription activity of the enhancer-
containing constructs when measured in HepG2 cells (Fig. 1A,
shown as ‘‘SS2 txn activity in vivo’’), indicating that transcription
from Start site 2 has an ability to be activated by enhancer
elements. This 13-bp DNA sequence does not correspond to any
of the previously described core promoter elements, nor does the
region surrounding the 13-bp sequence contain any other
previously known core promoter elements that can explain
transcriptional initiation from Start site 2 (Fig. 1A, bottom). The
13-bp sequence also does not contain any complete previously
known transcription activator-binding sites. Therefore, to deter-
mine what specific DNA sequence(s) within this region were
critical for the promoter activity, we carried out extensive
mutagenesis of the 13-bp sequence. We generated the complete
set of single nucleotide point mutants and tested their transcription
activity. Fig. 1B shows representative results of the in vitro
transcription assays using the wild-type and mutant templates.
Fig. 1C summarizes the results of the transcription assays of the 39
mutant promoters. The nucleotides critical for the core promoter
activity were located in the 11-bp region between nt1020 and
nt1030. The functionally tolerant range of a single base change
from the HBV sequence (i.e., the sequence that showed higher
than 25% of the wild-type promoter activity) was
VCYCRTTRCMY.
The core promoter element XCPE2 also drives
transcription from promoters in the human genome
Since HBV genes are transcribed by the host RNA pol II, we
were curious to see if XCPE2 is also utilized in human gene
promoters. A human promoter database DBTSS (Version 6.0;
http://dbtss.hgc.jp/, covering 15,262 genes in the human
genome) was searched for the XCPE2 consensus sequence. Since
most human genes have multiple promoters, individual promoters
of such genes have their own entries in DBTSS that can be
individually searched for sequence motifs. They are termed
alternative promoters AP1, AP2, etc. However, within individual
promoters, there are often multiple TSSs that show broad
distribution. For those promoters, one of the start sites has been
picked up to represent the promoter. Therefore, we first searched
relatively broad regions of promoters (between the nucleotides
2400 and +200 relative to the representative start sites) for the
XCPE2 consensus sequence. This search identified 297 genes that
contained XCPE2 sequences in the specified regions. Supplemen-
tal Table S1 shows a short list of the identified genes that have one
or more previously mapped start sites within regions +/220 bp
from the XCPE2 sequences. The candidate human promoters
appeared either typically to have an array of multiple start sites
that had been detected at different frequencies, or to be the
promoters for which start sites were still poorly mapped (Table S1).
In the candidate promoters, we could find a number of start sites
that occurred exactly at or near the positions expected to be driven
by XCPE2. It is possible that more XCPE2-driven start sites will
be identified as the determination of TSSs for the database
becomes more complete. However, to fairly determine whether
the XCPE2 sequences found in these promoters were actually
functional, it seemed necessary to analyze TSSs of individual
promoters by direct analyses of RNA transcripts such as primer
extension analysis. Direct analysis of TSSs has some advantages
over searching a promoter database when analyzing promoters
that are present in CpG islands, because of the way the promoter
database has been made: DBTSS was made using the information
on 59 ends of cDNA clones present in cDNA libraries that were
constructed through a process involving reverse transcription,
PCR, cloning to a plasmid, and amplification of the library. It is
known that highly GC-rich DNAs are often difficult to be PCR
amplified, are easily structurally rearranged during cloning, and
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cDNA clones tend to be amplified more efficiently than original
clones during cDNA library amplification [16,17]. Therefore,
TSSs in CpG islands are potentially incompletely represented in
the database.
To directly identify TSSs of cellular promoters, we cloned
several candidate XCPE2-containing human promoters and
conducted in vitro transcription assays. As shown in Fig. 2A and
summarized in Table S1, we were able to detect TSSs at the
positions expected to be driven by XCPE2 in these promoters. For
example, the TSS of ‘‘Regulator of G-protein signaling like 2’’
reported in DBTSS (shown by black asterisk in Fig. 2A and Table
S1) exactly matched the position expected to be driven by XCPE2
(shown by red asterisk in Fig. 2A) and one of the TSSs detected by
our in vitro transcription assay (shown by green asterisks in Fig. 2A,
and by red asterisks in Table S1). Even in the case of ‘‘Ankyrin
repeat and SOCS box-containing protein’’ and
ENST00000268533 for which no start sites had yet been mapped
at XCPE2 in DBTSS, we could detect the start sites at the
positions expected if driven by the XCPE2 sequences. The
XCPE2 start site in the ‘‘Regulator of G-protein signaling like 2’’
promoter appeared shifted slightly (2 or 3 bp) upstream from the
usual +1 site for XCPE2, but that may be explained by the
observation shown in Fig. 1B that nucleotide exchange at the +1
position (nt1029 of HBV sequence) appeared to influence start site
selection. In our previous study of XCPE1 core promoter
consensus sequence, we also observed minor start site shifts when
the consensus sequence diverged from the original XCPE1
sequence in the HBV DNA [6].
Since the XCPE2-driven TSS in the promoter of ‘‘Ankyrin
repeat and SOCS box-containing protein’’ has not been recorded
in DBTSS, we additionally analyzed transcripts from this
promoter produced in vivo, i.e., in transiently transfected cells, by
primer extension (Fig. 2B). Since the promoter region we cloned
(2480 to +46 relative to the expected TSS driven by the XCPE2)
did not necessarily contain whole promoter (and enhancer) of this
gene, the level of transcription was very low, but we were able to
detect TSSs at the position expected to be driven by XCPE2
(shown by arrows in Fig. 2B). The level of transcription of
ENST268533 was below the detection limit in our transiently
transfection & primer extension experiments under the conditions
used, likely due to lack of enhancer in our promoter construct.
However, we have observed consistent TSS selection patterns
between in vivo transcription and our in vitro transcription for all of
the more than 15 gene promoters we have analyzed (Tokusumi et
al. (2007), this study, and unpublished results).
To further examine if the XCPE2 sequences in these promoters
are functioning as core promoter elements, we mutated the
XCPE2 sequences and tested the effect of the mutations on the
promoter activity. Strikingly, the XCPE2 mutations specifically
abolished transcription from the start sites at the position expected
to be driven by XCPE2 with minimal influence to other
neighboring start sites (Fig. 2A). It should be noted that there is
a sequence TTACACT in the promoter of ‘‘Regulator of G-
protein signaling like 2’’ which matches the Inr consensus
sequence YYA
+1NWYY, partially overlapping with later half of
the XCPE2 sequence CCCCATTACAC. However, this Inr
sequence was found to be non-functional in this context because
our mutation (CCCCATTACACT to CCCAATTAAACT)
which changed the XCPE2 sequence into a non-XCPE2 sequence
kept the Inr sequence within its consensus but resulted in a large
transcriptional inhibition from the expected TSS. Thus, transcrip-
tion from the start site expected to be driven by XCPE2 appears to
be indeed driven by XCPE2 but not by the Inr sequence. These
results verify that XCPE2 is indeed used for transcription from the
specific sites in these human promoters. To determine what DNA
sequences are important for transcription from each of other start
sites in these promoters, extensive mutagenesis of individual
promoters will be required. However, our results concerning
XCPE2 sequences suggest that the other individual TSSs may be
driven specifically by their each independent core promoter
elements but not by XCPE2. In this sense, promoter recognition
by the transcriptional machinery appears specific but the
machinery may recognize a number of different sequences as
core promoter elements.
Examination of TFIID requirement for transcription from
XCPE2-containing promoters
To gain insight into mechanisms of transcriptional initiation
from this class of promoters, we started investigating which general
transcription factors are required. Among the known GTFs,
TFIID has been shown to play a central role in promoter
recognition for not only TATA box-containing promoters but also
of DPE-, Inr-, or DCE-containing promoters. TFIID consists of
TBP and about 15 TAF subunits. TBP recognizes TATA box;
TAF6 and TAF9 recognize DPE; TAF1, TAF2, and TBP together
recognize a class of Inr; and TAF1 recognizes DCE [7,11,18,19].
Therefore, we first examined requirements for the TFIID
complex. To analyze TFIID, it is important to keep in mind that
there are other transcription factors that share some subunits with
TFIID. For example, STAGA contains TAF5, 6, 9, 10, and 12
[20] and TFTC contains TAF2, 4, 5, 6, 7, 9, 10, and 12 [21]. TBP
Figure 1. Determination of the core promoter element driving transcription from HBV X mRNA Start site 2. (A) Schematic of the HBV
enhancer 1-X promoter region and the deletion mutants used for mapping of the minimal promoter for transcription from Start site 2. Different HBV
enhancer 1-X promoter fragments (nucleotide numbers of the boundaries shown) were cloned into a CAT reporter plasmid and used as the template
for in vitro transcription. Summary of the in vitro transcription analyses are schematically shown. The bent arrows show that accurate transcription
from Start site 2 [6,47] was detected with the indicated constructs. Being the same thicknesses of the bent arrows indicate about the levels of
transcription detected by in vitro transcription assays. Absence of the bent arrows on the promoter region indicates no detectable transcription from
the particular DNA fragments in the right direction. On the right ends, relative transcription activity of each construct in vivo (in transfected HepG2
cells) measured by CAT assay is shown as ‘‘SS2 txn activity in vivo’’. The template pXStNc?DSS1CAT has mutation at the Start site 1 core promoter so
that only transcription from Start site 2 can be measured. The DNA sequence around the Start site 2 minimal promoter region is shown at the
bottom. The 13-bp minimal promoter region is underlined and the position of Start site 2 is shown by a bent arrow. (B) In vitro transcription assays of
the wild-type and point-mutated minimal promoters for the Start site 2. The nucleotides within the 13-bp minimal promoter region were individually
mutated into three other nucleotides, and the transcription activity of the mutants was assayed in vitro. Primer extension products corresponding to
Start site 2 are shown. The levels of transcription from mutant templates were quantified by phosphor-imager analysis. (C) Summary of site-directed
mutagenesis. The in vitro transcription assays were repeated at least three times with several independent preparations of template DNAs, and
average activity of each mutant relative to that of the wild-type minimal promoter was calculated. Promoter activities of mutants are categorized into
three groups based on their relative activity to the wild-type promoter: pink, $50%; yellow, 50–25%; gray, ,25%. The consensus sequence deduced
from our analysis is shown at the bottom of the figure.
doi:10.1371/journal.pone.0005103.g001
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Furthermore, a recent report suggested TFIID can have a stable
core sub-complex (consisting of TAF4, 5, 6, 9, and 12) [22].
Therefore, to evaluate contribution of TFIID to XCPE2-driven
transcription, we treated crude nuclear extracts (NEs) with
antibodies against several TFIID subunits, including TFIID-
specific subunits (TAF1 and TAF11) and the subunits shared by
other factors (TAF4, and TAF6, and TBP). Then, we carried out
in vitro transcription assays using the immunodepleted NEs. As
shown in Fig. 3A, depletion of the tested TAFs and TBP all
reduced transcription activity to some extent, indicating that
TAF1, 4, 6, 11, and TBP were all involved in the transcription
from the X gene Start site 2. However, it was interesting that
depletion of the shared subunits TAF4, TAF6, and TBP showed a
severer transcriptional reduction than that of the TFIID-specific
subunits TAF1 or TAF11. In these experiments, we used the
whole enhancer 1/X promoter template pBS-HBXB [6] so that
we could also monitor transcription from Start site 1. We found
that transcription from start sites 1 showed similar responses to the
immunodepletion.
To help understand why TAF1- and TAF11-depletion showed
weaker transcriptional inhibition than TAF4-, TAF6-, or TBP-
depletion, we examined the protein levels of these subunits after
the immunodepletion (Fig. 3B). We found that all of the TFIID
antibodies used here (anti-TAF1, anti-TAF4, anti-TAF6, anti-
TAF11, and anti-TBP) largely reduced the levels of their own
target antigens, but also relatively efficiently co-depleted (reduced)
all of the other TFIID subunits tested except TAF11 (Fig. 3B).
These co-depletions were consistent with previous observations by
others that these subunits are part of the TFIID complex. Previous
observations have also suggested TAF11 may be less tightly
associated with the rest of the TFIID subunits than TAF1, 4, 6,
and TBP do [19,22]. Therefore, the weak transcriptional
inhibition by anti-TAF11 treatment we observed is likely to reflect
a weak co-depletion of other TFIID components. The observation
that efficient depletion of TAF11 itself did not result in a loss of
transcriptional activity indicates that TAF11 may not be a critical
component of TFIID for X gene transcription.
The weak transcriptional inhibition by TAF1-depletion may be
a reflection of multiple pathways for X mRNA transcription that
could include TAF1-independent transcription using free TBP or
an incomplete (TAF1-free) TFIID complex etc. However, it may
also be due to relative incompleteness of TFIID depletion by the
anti-TAF1 in this particular experiment, because in the immuno-
Figure 2. XCPE2 drives transcription from human promoters. (A) In vitro transcription analyses of wild-type and XCPE2-mutated promoter
templates. Sequence ladders were made using the same sets of templates and primers as those for the primer extension analyses. Arrows and red
asterisks (*) show the TSSs at the position expected to be driven by XCPE2. Green asterisks show the nucleotide positions of other start sites detected
in our in vitro transcription assays. Black asterisks show the nucleotide positions of start sites recorded in the DBTSS database. (B) Primer extension
analysis of Ankyrin repeat and SOCS box-containing protein mRNA produced in transfectecd HepG2 cells, showing that the same TSSs driven by
XCPE2 as in vitro transcription assays were detected. Arrows and red asterisks show the TSSs driven by XCPE2.
doi:10.1371/journal.pone.0005103.g002
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more extensively depleted of TAF1 by treating with anti-TAF1
twice, we observed stronger transcriptional inhibition and co-
depletion (reduction) of TAF4 and TAF6.
Free TBP, instead of the complete TFIID complex, could
drive X gene transcription without cooperation with
TAFs
Nevertheless, we wanted to make clear whether free TBP could
drive transcription from XCPE2 promoters, with the following
reasons. [1] Since depletion with anti-TAF4, anti-TBP, and TAF6
inhibited X gene transcription more efficiently than depletion with
anti-TAF1 in the experiments shown in Fig. 3, there was a
possibility that free TBP might be able to function in conjunction
with some TAF1-free TAF4/TAF6-containing complexes (i.e.,
TFIID sub-complex, STAGA, or TFTC). [2] In our previous
study examining transcription from Start site 1 of the HBV X
gene, we found that either free TBP or the complete TFIID
complex could restore XCPE1-driven transcription to TBP-
depleted NE. We were curious to see whether it is also the case
for XCPE2-driven transcription. [3] In yeast cells, a free form of
TBP exists and works with SAGA complex to drive TATA-
containing promoters [23].
In order to determine whether free TBP could drive
transcription form XCPE2 promoters, we carried out an in vitro
TBP add-back experiment. We first estimated how much TBP was
present in the NE by western blotting. Since 1 ml of our NE
showed about the same intensity of signal as 1 ng of purified
recombinant TBP (Fig. 4A), 7.5 ml of NE which was going to be
used for the in vitro transcription assays was estimated to contain
about 7.5 ng of TBP. Therefore, we used 1, 3, 10, and 30 ng of
purified TBP for the in vitro add-back experiments (Fig. 4B and C,
lanes 5–8). As a control, we used purified TFIID that contained 1
or 3 ng of TBP (Fig. 4B and C, lanes 3 and 4). We found that free
TBP could restore the X gene Start site 2 transcription activity to
the TBP-depleted NE almost as efficiently as purified TFIID. This
result suggests that transcription from the X promoter Start site 2,
like Start site 1 [6], could use either a free form of TBP or the
TFIID complex. When higher levels of TBP (10 ng and 30 ng)
were added, X gene transcription was further activated. As a
control, we monitored transcription from Sp1-TATA promoter,
which shows activated transcription in a TFIID-dependent
manner [24]. Transcription from Sp1-TATA was much more
efficiently restored by TFIID than TBP, indicating that our TFIID
was functional. The higher doses of free TBP rather inhibited Sp1-
TATA transcription probably by competitively inhibiting TFIID
binding to the TATA box. We saw an extra band several base-pair
upstream of Start site 2 which became much stronger than original
when high concentrations of free TBP were added. This band
probably reflects transcriptional initiation induced by TBP-
binding to the upstream region (perhaps the sequence AACAATA
that is similar to TATA box) with loose sequence specificity. This
phenomenon was not observed when transcription assay was
carried out with the Start site 2 minimal promoter (Supplemental
Fig. S1), therefore, the transcripts corresponding to this extra band
are not likely to be driven by XCPE2.
Our results indicated that TFIID in NEs contribute to the in vitro
X gene transcription reactions, but if a free form of TBP is
available, free TBP can also promote efficient transcription (Figs. 3
and 4).
However, it was still unclear whether free TBP promotes X
gene transcription through cooperation with TAFs (i.e., in
conjunction with the core TFIID sub-complex, STAGA, or
TFTC) or without TAFs. To make this point clear, we tested if free
TBP could restore X gene transcription activity to the TAF4-
depleted NE by an in vitro add-back experiment. As shown in Fig. 5,
we found that the free TBP could promote X gene transcription
Figure 3. TFIID present in nuclear extracts contributes in X mRNA transcription, but TAF11 is dispensable. (A) In vitro transcription
assays of immmunodepleted nuclear extracts (NEs). To examine importance of TFIID for X gene transcription, TFIID was depleted from NEs using
antibodies raised against different TFIID subunits and the depleted NEs were tested for X gene transcription activity using the HBV enhancer-X
promoter construct. SS1 and SS2: primer extension products showing transcription from Start site 1 and Start site 2, respectively. The asterisk showsa
primer extension product that was not consistently observed. (B) Western blot analyses of the immunodepleted NEs. Depleted NEs were examined
for the levels of TAF1, TAF4, TAF6, TAF11, and TBP.
doi:10.1371/journal.pone.0005103.g003
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and other TAF4-containing complexes such as TFTC or STAGA
are not necessary for XCPE2 transcription with free TBP. The
TFTC- or STAGA-independence of X gene transcription was
further demonstrated by the Gcn5-depletion experiment shown
later. Therefore, the X gene transcription with free TBP is carried
out through a mechanism different from that with TBP+SAGA for
yeast TATA-dependent transcription or the mechanism with
TFTC for the Inr-containing TATA-less transcription of TEF-1
(transcription-enhancer factor-1) gene [14].
We also wanted to examine the role of TAF1 in XCPE2
transcription in vivo. We used a ts13 cell line that has a TAF1
missense mutation [25] in its potential HAT (histone acetyltrans-
ferase) region, and shows TAF1-defective phenotype without
changing overall structure of TFIID at the non-permissive
temperature [26]. The ts13 cells were transfected with a reporter
plasmid driven by XCPE2 and cultured at either 33.5uC
(permissive temperature) or 39.5uC (non-permissive temperature)
(Fig. 6). As a control, transcription from TAF1-dependent cyclin A
promoter [27] was analyzed in parallel. As expected, the level of
cyclin A transcription was reduced about 15-fold upon inactivation
of TAF1 at 39.5uC. Under the same experimental conditions,
transcription by XCPE2 was only marginally decreased (about
1.3-fold) (Fig. 6). These results suggest that, in the absence of
functional TAF1, ts13 cells could use an alternative mechanism for
X gene transcription, i.e., a TAF1-independent mechanism either
using free TBP or a functionally incomplete (TAF1-inactive)
TFIID complex. This observation is consistent with the notion we
obtained from in vitro studies that XCPE2-containing promoters
can utilize either the complete TFIID complex or free TBP.
Mediator and TFIIB but not Gcn5 are required for X gene
transcription
The TFTC complex has been shown to contain subunits of the
core TFIID sub-complex, and to be able to drive transcription
from both TATA-containing and TATA-less Inr-containing
promoters [14]. To examine if TFTC is involved in the
transcription of the X gene, we examined the requirement for
Gcn5, the major subunit of TFTC. As shown in Fig. 7A, we found
that immunodepletion of Gcn5 did not change the X gene
transcription activity of the NE, suggesting that TFTC is not
required.
Figure 4. Transcription from X mRNA Start site 2 can use either a free TBP or the TFIID complex. (A) Examination of TBP concentration in
HeLa NE. Indicated amounts of HeLa NE and purified recombinant TBP were loaded on a SDS-PAGE gel, and TBP was detected by anti-TBP western
blotting. (B) In vitro transcription assays of the X gene (from Start site 2) and the Sp1-TATA templates (in a single two-template reaction). Control (lane
1) or TBP-depleted (lanes 2–8) NEs were tested for X gene or Sp1-TATA transcription in the absence (lane 2) or presence of 1 ml (lane 3) or 3 ml (lane 4)
of purified TFIID or the presence of 1 ng (lane 5), 3 ng (lane 6), 10 ng (lane 7), or 30 ng (lane 8) of purified recombinant TBP (1 ml of the TFIID used in
this experiment contained about 1 ng of TBP [6]). The enhancer-X promoter template was used to measure transcription from Start site 2. (C)
Quantification results of the transcription assay. Transcription assays were performed twice for the reaction with 30 ng TBP (lane 8 of panel A) and
four times for all of the other reactions. Brackets show standard errors of means.
doi:10.1371/journal.pone.0005103.g004
Figure 5. A free form of TBP can drive X gene transcription in
the absence of TAF4. HeLa NE was depleted with nothing (lane 1) or
with anti-TAF4 (lanes 2–5) and was mixed with the indicated amounts




PLoS ONE | www.plosone.org 7 April 2009 | Volume 4 | Issue 4 | e5103We have observed that anti-TBP, but not our anti-TAF1, could
co-precipitate the MED26-containing mediator complex, thus
TBP plus mediator might play an important role in X gene
transcription. As shown in Fig. 7B, we found that treatment of NEs
with anti-MED26 abolished transcription, suggesting that the
MED26-containing mediator complex is required for X gene
transcription. To further test the mediator requirement, we
purified MED26-containing complexes and asked whether the
purified MED26-containing complex restores X gene transcription
activity to the MED26-depleted NE. Since it has been reported
that the mediator complexes from different phosphocellulose
fractions (0.5 M or 0.85 M KCl eluates) might have different roles
in transcriptional control [28,29], we purified MED26-containing
complexes from both 0.5 M and 1 M KCl phosphocellulose
fractions (P.5 and P1.0) and tested their activity. The add-back
experiment further supported the idea that the MED26-containing
mediator complex is required for X gene transcription and showed
that the MED26 complexes from either phosphocellulose fractions
could support X gene transcription. We also carried out this
immunodepletion experiment using the minimal promoter
construct (pX1020-1032CAT shown in Fig. 1A) and obtained
essentially the same result (Fig. 7B lower panel). Since the minimal
promoter region does not contain any sequence-specific DNA-
binding activator binding sites, the result shows that the mediator
is required for ‘‘basal’’ transcription from Start site 2.
We also examined the requirement for TFIIB by an
immunodepletion and add-back experiment, and found that
TFIIB was required for X gene transcription (Fig. 7C).
X gene transcription with free TBP requires cooperation
with TFIIB, RNA pol II and the MED26-containing
mediator
Since we found that free TBP could activate X gene
transcription independently of TAF4, we next asked what other
factors are necessary for the TAF-free XCPE1- or XCPE2-driven
transcription. For this purpose, we added free TBP to various
immunodepleted NEs. As shown in Fig. 8, free TBP could activate
X gene transcription without TAF4, TAF6, or Gcn5 to a higher
level than observed for the untreated NE. However, without
MED26, RNA pol II, or TFIIB, activation by free TBP was largely
compromised, indicating that the mediator, RNA pol II, and
TFIIB have important roles separate from that of free TBP. The
small increases of transcription by TBP addition in the MED26-,
TFIIB-, or RNA pol II-depleted NE (Fig. 8, lanes 10, 12, and 14
relative to lanes 9, 11, and 13) were most likely the result of
transcription carried out by residual mediator, RNA pol II, or
TFIIB due to incomplete immunodepletion.
XCPE1 and XCPE2-containing cellular promoters show
the same GTF requirements as the HBV X gene promoter
We examined the GTF requirements for XCPE1- and XCPE2-
containing cellular promoters. HeLa cell NE was immunodepleted
Figure 7. Transcription from X mRNA Start site 2 requires
MED26-containing mediator and TFIIB but not Gcn5. (A) HeLa
cell nuclear extract (NE) was immunodepleted with control or anti-Gcn5
antibody. The depleted NEs were then tested for the level of depletion
by western blotting and for X gene transcription activity from the two
start sites using the enhancer-X promoter construct. (B) HeLa NE was
immunodepleted with control or anti-MED26 antibody. The depleted
NEs were then tested for the level of depletion and for X gene Start site
2 transcription activity using either the enhancer-X promoter construct
or the minimal promoter construct in the absence (lane 2) or presence
(lanes 3 and 4) of mediator complexes purified from P.5 (lane 3) or P1.0
(lane 4) phosphocellulose fractions. The response of the transcription
from Start site 1 has been reported [6]. (C) HeLa NE was immunode-
pleted with control or anti-TFIIB antibody. The depleted NEs were then
tested for depletion and for X gene transcription activity from the two
start sites using the enhancer-X promoter construct in the absence
(lane 2) or presence (lanes 3–5) of the purified TFIIB (10, 30, or 100 ng).
doi:10.1371/journal.pone.0005103.g007
Figure 6. TAF1 is marginally important for X gene transcription
in ts13 cells. ts13 cells were transfected with a firefly luciferase
reporter plasmid driven by the X gene core promoter 2 or the cyclin A
promoter. After 16 hr of incubation at the permissive (33.5uC) or
nonpermissive (39.5uC) temperature, the luciferase activity in transfect-
ed cells were measured and normalized for transfection efficiency.
Brackets show standard error of means.
doi:10.1371/journal.pone.0005103.g006
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XCPE1 and XCPE2 cellular promoters was analyzed. To enhance
levels of TAF1- and TAF11-depletion, we treated NE with TAF1
and TAF11 antibodies twice. The western blot analyses of
antibody treatments are shown in Fig. 9A, and the transcription
activity assays with the depleted NEs are shown in Fig. 9B. As a
control, we also carried out in vitro transcription of the X gene Start
site 2 minimal promoter (pX1020-1032CAT) using the same
depleted NEs. We found that the XCPE1- and XCPE2-driven
transcription in the cellular promoters show very similar GTF
requirements to those of the X promoter. Interestingly, many of
the other TSSs in these promoters also showed the same patterns
of GTF requirements, suggesting that there may be a common set
of factors utilized by dispersed promoters found in CpG islands.
TFIIB, TBP, RNA pol II, TFIIF, and mediator are not
sufficient for sequence-specific promoter recognition for
XCPE2-containing promoters
Since we have found that transcription from XCPE2-containing
promoters requires at least RNA pol II, TBP, mediator, and
TFIIB (Figs. 3, 7, 8, and 9), we wanted to know whether these are
sufficient for XCPE2 core promoter recognition. Some of the
previous studies on Inr-containing promoters have shown that
TBP (or TFIID), TFIIB, RNA pol II, and TFIIF could form a
stable complex (DBPolF complex) at the core promoters in an Inr
sequence-dependent manner [30,31]. Therefore, we additionally
purified RNA pol II and TFIIF and conducted EMSAs
(electrophoretic mobility-shift assays) with
32P-labeled probe
containing the X gene Start site 2 minimal promoter. As a
control, we conducted EMSAs using
32P-labeled adenovirus major
late (AdML) core promoter region (238 to +13) that has
previously been used to detect stable preinitiation complex
formation [32]. Fig. 10A shows our purified TFIIB, TFIIF,
TBP, RNA pol II, and mediator proteins, and Fig. 10B–E shows
the EMSAs. We found that when all of the factors were mixed
with the X gene Start site 2 promoter DNA, we could detect a
stable discrete band (Fig. 10B, lane 1 and Fig. 10C, lane 1). A
similar band was detected without the mediator (Fig. 10B, lane 2),
but it often disappeared if the mixture was incubated for a longer
time before the electrophoresis (An example is shown in Fig. 10C,
lane 2). If any of the other factors was removed from the mixture,
the band was not detected (Fig. 10B, lanes 3–6). Therefore, this
specific combination of GTFs may have activity to bind XCPE2-
containing promoter DNAs. However, if we added poly(dG-
dC)?poly(dG-dC) to the EMSA binding reactions, this factor-
specifically formed DNA-protein complex was not detected
(Fig. 10D). Therefore this XCPE2 DNA-protein complex we
observed did not appear to be formed sequence-specifically. In the
control EMSAs using the AdML probe, a stable DNA protein
complex was detected in the presence of TBP, TFIIB, RNA pol II,
and TFIIF (DBPolF) with or without mediator, and was resistant
to poly(dG-dC)?poly(dG-dC) (Fig. 10E, lanes 1 and 2) as expected.
This control EMSA, combined with our transcriptional activity
assays with the purified factors (Figs. 4, 5, and 7), indicates that our
purified factors are functional and therefore the lack of sequence-
specific XCPE2 recognition was not due to inactivity of the
purified factors. Taken together, we could detect a stable protein-
DNA complex formed on the XCPE2-containing X promoter
DNA with TBP, TFIIB, RNA pol II, TFIIF, and mediator, but
this combination of GTFs is still not sufficient for sequence-specific
promoter recognition that would explain site-specific transcrip-
tional initiation by XCPE2. Therefore, additional factors, such as
other previously known GTFs and/or cofactors, must be required
for specific transcriptional initiation from XCPE2-containing
promoters. This result suggests that the mechanism of XCPE2
promoter recognition is different from those previously described
for a class of Inr-containing TATA-less promoters.
Discussion
A new core promoter element XCPE2 that drives
transcription from TATA-less promoters containing
multiple transcriptional starts sites
In this study, we identified a new core promoter element
XCPE2 that drives transcription from the second TSS of the HBV
X gene. XCPE2 also appears to drive transcription typically from
one of the TSSs present in human promoters that show clusters of
TSSs. It is interesting to find that there are functional similarities
between XCPE2 and our previously identified core promoter
element XCPE1. First, both XCPE1 and XCPE2 are located
around the start sites (28,+2 for XCPE1 and 29,+2 for
XCPE2). Second, the XCPE1 and XCPE2 sequences are mainly
found in TATA-less promoters that often show multiple start sites.
Finally, transcription from both start sites 1 and 2 displays the
same or very similar GTF requirements. However, there are also
some differences between XCPE1 and XCPE2; first, their
Figure 8. X gene transcription with free TBP requires mediator,
TFIIB, and RNA pol II but not TAFs or Gcn5. HeLa NE was
immunodepleted of the indicated factors and tested for X gene
transcription activity with or without addition of free TBP. Abolishment
of X gene transcription by TAF4-, TAF6-, TBP-, MED26-, TFIIB-, or RNA
pol II-depletion (lane 1 vs. lanes 3, 5, 7, 9, 11, and 13) confirms that these
factors contribute to the X gene transcription but Gcn5 doesn’t (lane 1
vs. lane 15). The strong activation of X gene transcription by addition of
a higher-than-endogenous level of free TBP to the mock-, TAF4-, TAF6-,
TBP-, and Gcn5-depleted NEs (lanes 2, 4, 6, 8, and 16) indicates that
these depleted factors were not necessary for X gene transcription by
the mechanism using free TBP. In contrast, the absence of such
activation by addition of free TBP to MED26-, TFIIB-, or RNA pol II-
depleted NE (lanes 10, 12, and 14) indicates that these three factors are
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VCYCRTTRCMY), and second, XCPE1 requires activator-
binding site(s) to show detectable transcription but XCPE2 can
show a detectable level of transcription by itself.
Multiple studies have demonstrated the presence of enhancer-
promoter specificity, i.e., different core promoters exhibit different
and selective responses to enhancers, indicating that the
combination of a specific promoter and enhancers determines
the transcriptional regulation pattern for each gene [33–36]. The
molecular basis of enhancer-promoter specificity is not completely
clear, but one of the potential explanations may be that different
core promoters utilize different sets of GTFs and cofactors [37] so
that the regulatory signals can be differently transmitted, received,
and interpreted. Therefore, determination of the complete set of
factors that contribute to transcription of XCPE1- or XCPE2-
driven promoters is a challenging task but appears critical to
further our understanding of transcription mechanisms of a large
number of TATA-less dispersed promoters.
Mechanisms of transcription from XCPE1-and XCPE2-
containing promoters are different from previously
described mechanisms
To gain insights into mechanisms of XCPE1-and XCPE2-
driven transcription, we examined requirements of several GTFs.
Our immunodepletion and add-back experiments suggest that
transcription from XCPE1- and XCPE2-containing promoters
requires at least TFIIB, TFIID (or free TBP), RNA pol II and the
mediator complex present in the nuclear extracts but not Gcn5.
The observation that XCPE1 and XCPE2 could drive transcrip-
tion without TAFs indicates that mechanisms for XCPE1- and
XCPE2-containing promoters are different from the TFIID-
dependent mechanisms described for the Inr- and DPE-containing
promoters [18,19,38]. The observation that XCPE1- and XCPE2-
driven transcription could occur without Gcn5 means that the
mechanisms for XCPE1- and XCPE2-driven transcription are
also different from the one described for yeast TATA-containing
promoters using free TBP and SAGA (Spt-Ada-Gcn5) complex
[23] or the one described for TATA-less, Inr-containing promoter
using TFTC (TBP-free TAFII-containing complex) [14].
Previous studies have reported that the mediator complex
purified from one of the phosphocellulose fractions (the 0.85 M
KCl fraction) plays a role in supporting basal transcription [28,29].
However, these studies clearly showed requirement of mediator for
only either basal transcription from TATA-containing promoters
or activated transcription from TATA-less Inr-containing pro-
moters, and it was not clear whether mediator was required for
basal transcription of their TATA-less promoters because the level
of basal transcription from the promoter was almost background.
In our previous study on XCPE1, we were also unable to
discriminate whether mediator was required for basal transcription
Figure 9. XCPE1 and XCPE2-containing cellular promoters show the same GTF requirements as HBV X gene promoter. (A) Western
blot analyses of depleted NEs. HeLa NE was immunodepleted as indicated and the levels of target factors as well as other GTFs were examined by
western blotting. (B) In vitro transcription assays of the immunodepleted NEs. Transcription activities for the XCPE2-containing promoters
(ENST268533, NM_16114, and NM_32267), an XCPE1-containing promoter (NM_024811), and the X gene Start site 2 minimal promoter were
examined. Arrows show the transcripts starting at the positions expected to be driven by XCPE2 or XCPE1.
doi:10.1371/journal.pone.0005103.g009
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dent core promoter [6]. In this study, since the XCPE2 can drive a
basal transcription by itself that is clearly distinguishable from
background, we were able to clearly show an example of mediator
requirement for basal transcription from a class of TATA-less
promoters, i.e., XCPE2-containing promoters.
TAF-free transcription
In this study, immunodepletion analyses showed that transcription
from XCPE1- or XCPE2-containing promoters use at leastRNA Pol
II, TFIIB, mediator, and TFIID present in the NE as critical factors.
However, we also showed that these promoters can use free TBP
instead of TFIID if free TBP is available. In mammalian cells, it
Figure 10. Sequence-nonspecific stable complex formation by TBP, TFIIB, RNA pol II, TFIIF, and mediator on X gene Start site 2
promoter. (A) SDS-PAGE analyses of purified factors. Purified recombinant TFIIB, TFIIF, and TBP were analyzed by Comassie staining. RNA pol II and
mediator were analyzed by silver staining. Bands are labeled by comparing the previously published patterns. The mediator complexes shown are
bound to M2 beads, from which they were eluted with FLAG peptides and used for EMSA. (B) EMSA with the X gene Start site 2 minimal promoter
probe. The
32P-labeled probe was mixed with indicated factors without carrier DNA. B, TFIIB; D, TBP; P, RNA pol II; F, TFIIF; and M, mediator. The
mixtures were incubated for 30 min before electrophoresis as described in Materials and Methods. The experiments shown were performed using the
mediator complex from the phosphocellulose fraction P1.0, but the complexes from the P.5 fraction showed the same results. (C) XCPE2 DNA and
TFIIB/TBP/Pol II/TFIIF form an unstable complex. The same EMSA as is shown in Fig. 10B was performed except that the binding mixtures were
incubated for 1 hr 20 min before electrophoresis. (D) The XCPE2 DNA/TFIIB/TBP/Pol II/TFIIF/mediator complex was not observed in the presence of
poly(dG-dG)? poly(dG-dC). (E) EMSA showing TFIIB/TBP/Pol II/TFIIF complex formation on the adenovirus major late (AdML) promoter. The binding
mixtures were incubated for 30 min before electrophoresis. The same results were obtained when the mixtures were incubated for a longer period
(2 hrs, data not shown).
doi:10.1371/journal.pone.0005103.g010
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the complete TFIID complex, and the TFIID sub-complexes exist.
However, TAF-free transcription may also be utilized in mammalian
cells because it has been shown that yeast cells utilize a free form of
TBP for transcription ofTATA-containing promoters by cooperation
with the SAGA complex [23,39]. In addition, previous in vitro
reconstitution studies on TATA-containing promoters using HeLa
cell extracts showed that TAFs are not absolutely required for
activated transcription depending on core-promoter sequences
around the TSSs, indicating that there may be alternative
transcriptional initiation pathways which is TAF-independent
[40,41]. It would be interesting to compare GTF requirements for
such TAF-free transcription from TATA-containing promoters and
those for transcription from XCPE1/XCPE2 promoters.
Levels of TAFs in mammalian cells may substantially change
according to the cell cycle phases or physiological conditions etc.,
consequently, the pool of TFIID in the cells may include certain
amounts of sub-complexes and free TBP. If the levels of TAFs
become low, the XCPE1 and XCPE2 classes of TATA-less genes
would be continuously expressed, while expression of other TAF-
dependent genes would be reduced. In higher eukaryotes, transcrip-
tion mechanisms using a more diverse set of core promoter structures
and different GTFs utilization might have evolved to enable the more
complex and flexible regulation required for the multi-cellular
environment. In order to further clarify mechanisms of transcrip-
tional regulation for XCPE1 and XCPE2-containing promoters, our
next goals will be to complete determination of factor requirements
for transcription from XCPE1 and XCPE2 promoters by in vitro
reconstitution either in the presence or absence of TAFs, and to
identify XCPE1 and XCPE2 recognition factors.It willbe interesting
to also find what DNA sequences drive transcription from other TSSs
in the XCPE1 and XCPE2-containing promoters or other multiple
TSS-containing dispersed promoters. Information on what sub-
fractions of TFIID are present in vivo will be also critical.
Materials and Methods
Plasmids
The HBV X gene DNAs are derived from a HBV strain (subtype
adr) [42]. Nucleotide position no.1 (nt1) of this strain corresponds to
nt127 of the strain whose EcoRI site is designated as nt1. The wild-
type CAT (chloramphenicol acetyltransferase) reporter plasmid
containingthe minimal promoter for Start site 2 of the HBV X gene
mRNA has been described [6]. For extensive point mutagenesis of
the X core promoter 2, oligonucleotides containing mutated X core
promoter2 sequenceswere synthesized,annealed, and ligatedinto a
CAT reporter plasmid pSV00CAT [43]. A control in vitro
transcription template Sp1-TATA which contains multiple Sp1-
binding sites and a TATA box from adenovirus E1B promoter has
been described [24]. XCPE2-containing human promoter regions
covering from about 500 bp upstream to about 50–100 bp
downstream of XCPE2 sequences were cloned from Huh-7
hepatocellular carcinoma cell genomic DNA by PCR, and cloned
into pSV00CAT. Subsequently, mutations of XCPE2 sequences
were introduced by the Quick Change procedure (Stratagene).
DNA sequences of all the clones (the wild-type and mutated
promoters) were verified by DNA sequencing.
Immunodepletion and in vitro transcription
The anti-TBP and anti-MED26 antibodies have been described
[6]. Anti-Gcn5 and anti-TFIIB antibodies were from Santa Cruz
Biotechnology, Inc. Anti-TAF11, anti-TAF6, and anti-RNA poly-
merase II (8WG16) were purchased from Abcam (ab50557), Bethyl
laboratory, and Millipore, respectively. Anti-TAF1 was raised by
immunizing rabbits with a TAF1 fragment (amino acids 1363–1638)
which is a longer fragment than the fragment used to raise the
previous anti-TAF1 [6]. Anti-human TAF4 was raised by immuniz-
ing rabbits with a TAF4 fragment (a.a. 1–197) and affinity-purified
using the same protein fragment. Immunodepletion experiments and
in vitro transcription assays were performed as described [6].
Purification of TBP, TFIIB, TFIID, the mediator, TFIIF, and
RNA pol II
Endogenous TFIID, FLAG-tagged MED26-containing media-
tor complex, and recombinant TBP were purified as described [6].
Recombinant untagged human TFIIB was expressed in E. coli and
purified with Poros HS and Poros HE1 (Applied Biosystems)
columns. Recombinant human TFIIF was purified as described
previously [44]. RNA polymerase II was purified from HeLa cells
that stably express FLAG-His-tagged Rpb3 as described [45].
EMSA (electrophoretic mobility-shift assay)
Purified TFIIB (0.6 pmol), TBP (0.6 pmol), RNA pol II
(0.3 pmol), TFIIF (1 pmol), and mediator (about 0.1 pmol or
200 ng) were mixed with 0.5–1.0 ng of
32P-labeled DNA probe in
the presence of 20 mM Hepes, 10% Glycerol, 60 mM KCl, 4 mM
MgCl2, and 4 mM DTT in a 15 ml reaction. In some reactions,
25 mg/ml poly(dG-dC)?poly(dG-dC) was added. After incubation
at 30uC for 30 minutes or .1 hr, the mixture was analyzed by
PAGE using a gel containing 4% acrylamide (37.5:1), 2.5%
Glycerol, and 0.56TBE.
Analysis of transcription from the XCPE2-containing
promoter in transfected cells
HepG2 cells were transfected with CAT reporter plasmids
driven by the XCPE2-containing promoters. Two days after
transfection, poly(A)
+ RNAs were purified and transcripts from the
CAT reporter plasmids were analyzed by primer extension. For
CAT reporter assays, whole cell extracts were prepared from
transfected cells and CAT activity was measured as described [46].
Supporting Information
Table S1 Human gene promoters that contain XCPE2
sequences around previously identified transcriptional start sites.
A list of candidate human genes that utilize XCPE2
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Figure S1 Activation of the X gene transcription from Start site
2 by addition of free TBP
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